Revision: June 14, 2019, 9:06 a.m.
HB 359 - VERSION ADOPTED BY BOTH BODIES
7Mar2019... 0344h
05/23/2019 2222s
2019 SESSION
19-0787
01/04
HOUSE BILL 359
AN ACT relative to warning labels on prescription drugs containing opiates.
SPONSORS: Rep. Loughman, Rock. 21; Rep. Gourgue, Straf. 25; Rep. Josephson, Graf. 11; Rep. Griffith, Hills. 18; Rep. Muscatel, Graf. 12; Sen. Sherman, Dist 24; Sen. Reagan, Dist 17; Sen. Rosenwald, Dist 13
COMMITTEE: Commerce and Consumer Affairs
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill requires any drug which contains an opiate dispensed by a health care provider or pharmacy to have an orange sticker on the cap or dispenser and a warning label regarding the risks of the drug.
This bill also requires the governor's commission on alcohol and drug abuse prevention, treatment, and recovery to develop a handout on the risks of opioids and how to mitigate them for persons who are receiving prescriptions for opioids.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
7Mar2019... 0344h
05/23/2019 2222s 19-0787
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to warning labels on prescription drugs containing opiates.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Controlled Drugs Containing Opiates; Warning Label Required. Amend RSA 318-B by inserting after section 16 the following new section:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.
2 New Paragraph; Governor's Commission on Alcohol and Drug Abuse, Prevention, Treatment, and Recovery; Duties. Amend RSA 12-J:3 by inserting after paragraph VI the following new paragraph:
VII. Develop a handout which shall describe the risks of opioid use and how to mitigate them for the purposes of RSA 318-B:16-a.
3 Effective Date. This act shall take effect January 1, 2020.